Drugs Made In America Acquisition Corp. (DMAAR) Non Operating Income (2025 - 2026)

Drugs Made In America Acquisition (DMAAR) has reported Non Operating Income for 2 consecutive years, with $1.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non Operating Income fell 23.0% year-over-year to $1.9 million; the trailing twelve-month figure through Jun 2026 stood at $9.0 million (changed N/A YoY), and the FY2025 full-year result was $8.8 million, changed N/A from the prior year.
• Non Operating Income fell to $1.9 million in Q2 2026 per DMAAR's latest filing, from $2.3 million in the prior quarter.
• Across five years, Non Operating Income topped out at $2.4 million in Q3 2025 and bottomed at $1.9 million in Q2 2026.